V L Kan

Practice Guidelines for Diseases Caused by Aspergillus

D. A. Stevens, V L Kan, Marc A. Judson et al. · Clinical Infectious Diseases · 2000 · 797 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Comparative Safety, Tolerance, and Pharmacokinetics of Amphotericin B Lipid Complex and Amphotericin B Desoxycholate in Healthy Male Volunteers

V L Kan, John E. Bennett, Michael Amantea et al. · The Journal of Infectious Diseases · 1991 · 94 citations

Medicine, Clinical Pharmacokinetics, Pharmacology +8

Efficacies of four antifungal agents in experimental murine sporotrichosis

V L Kan, John E. Bennett · Antimicrobial Agents and Chemotherapy · 1988 · 52 citations

Medicine, Infectious Diseases, Pharmacology +17

Tolerance to cryptococcal polysaccharide in cured cryptococcosis patients: failure of antibody secretion in vitro.

David K. Henderson, V L Kan, John E. Bennett · PubMed · 1986 · 26 citations

Life Sciences, Immunology, Infectious Diseases +15

Enhanced oxidative killing of azole-resistant Candida glabrata strains with ERG11 deletion

V L Kan, Antonia Geber, John E. Bennett · Antimicrobial Agents and Chemotherapy · 1996 · 25 citations · Full text

Life Sciences, Microbiology, Antimicrobial Resistance +16